---
title: Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA
  Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell
  Lung Cancer Patients
date: '2023-09-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37686200/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230910180950&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Analysis of circulating tumor DNA (ctDNA) is a potential minimally invasive
  molecular tool to guide treatment decision-making and disease monitoring. A suitable
  diagnostic-grade platform is required for the detection of tumor-specific mutations
  with high sensitivity in the circulating cell-free DNA (ccfDNA) of cancer patients.
  In this multicenter study, the ccfDNA of 72 patients treated for advanced-stage
  non-small cell lung cancer (NSCLC) was evaluated using the UltraSEEK^(®) Lung Panel
  on ...
disable_comments: true
---
Analysis of circulating tumor DNA (ctDNA) is a potential minimally invasive molecular tool to guide treatment decision-making and disease monitoring. A suitable diagnostic-grade platform is required for the detection of tumor-specific mutations with high sensitivity in the circulating cell-free DNA (ccfDNA) of cancer patients. In this multicenter study, the ccfDNA of 72 patients treated for advanced-stage non-small cell lung cancer (NSCLC) was evaluated using the UltraSEEK^(®) Lung Panel on ...